DRDO shares directions for usage of 2DG drug in Covid-19 patients
The 2DG drug is strictly prohibited for use in pregnant and lactating women, and those below 18 years.
The Defence Research and Development Organisation has shared important details and usage directions of the recently launched drug 2-deoxy-D-glucose (2-DG) for covid-19 patients.
As per the information tweeted by DRDO, the 2DG medicine can be given to Covid-19 patients under the care and prescription of doctors.
The national drug regulator, Drugs Controller General of India (DCGI) has also approved that the drug should be administered by doctors as early as possible among patients with moderate to severe symptoms for a duration of up to 10 days.
The 2DG drug is strictly prohibited for use in pregnant and lactating women, and those below 18 years.
Source DRDO’s official Twitter handle
The 2DG medicine can be given to Covid-19 patients under the care and prescription of doctors. Directions for usage of this drug for Covid-19 patients as per DCGI approval are attached here for reference. For all queries regarding #2DG, please write to 2DG@drreddys.com pic.twitter.com/x19ayBoToG
— DRDO (@DRDO_India) June 1, 2021
2- DG is an anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by INMAS, a lab of DRDO, in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad.